References

  1. Blanco S, Ayensa C, Agud J, Zubizarreta J. Paralysis of the respiratory muscles in polymyositis; Treatment with cyclophosphamide pulses. Rev Clin Esp. 1992; 191(2):111-2. PubMed | Google Scholar

  2. Marie I, Hachulla E, Hatron P-Y et al. Polymyositis and dermatomyositis: short term and long term outcome, and predictive factors of prognosis. Journal of Rheumatology. 2001; 28(10): 2230-7. PubMed | Google Scholar

  3. Marie I, Hatron P-Y, Dominique S, Cherin P, Mouthon L, Menard J. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis and Rheumatism. 2011; 63(11): 3439-47. PubMed | Google Scholar

  4. Marie I, Lahaxe L, Benveniste O et al. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody. British Journal of Dermatology. 2010; 162(2): 337-44. PubMed | Google Scholar

  5. Fathi M, Lundberg IE, Tornling G. Pulmonary complications of polymyosistis and dermatomyositis. Semin Respir Crit Care Med. 2007;28(4):451-8. PubMed | Google Scholar

  6. Marie I, Dominique S, Rémy-Jardin M, Hatron PY, Hachulla E. Interstitial lung diseases in polymyositis and dermatomyositis. Rev Med Interne. 2001;22(11):1083-96. PubMed | Google Scholar

  7. Blumbergs PC, Byrne E, Kakulas BA. Polymyositis presenting with respiratory failure. J Neurol Sci. 1984;65(2):221-9. PubMed | Google Scholar

  8. Flusche G, Unger-Sargon J, Lambert DH. Prolonged neuromuscular paralysis with vecuronium in a patient with polymyositis. Anesth Analg. 1987;66(2):188-90. PubMed | Google Scholar

  9. Ganta R, Campbell IT, Mostafa SM. Anaesthesia and acute Dermatomyositis polymyositis. Br J Anaesth. 1988;60(7):854-8. PubMed | Google Scholar

  10. Marie I, Mouthon L. Therapy of polymyositis and dermatomyositis. Autoimmunity Reviews. 2011;11(1): 6-13. PubMed | Google Scholar

  11. Cherin P, Herson S, Wechsler B et al. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. The American Journal of Medicine. 1991;91(2)162-8. PubMed | Google Scholar

  12. Cherin P, Pelletier S, Teixeira A et al. Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis & Rheumatism. 2002;46(2) 467-74. PubMed | Google Scholar

  13. Elovaara I, Apostolski S, Van Doorn P et al. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. European Journal of Neurology. 2008;15(9) 893-908. PubMed | Google Scholar